Protagonist Therapeutics, Inc. · NASDAQ:PTGX
The Vanguard Group reported a 8.65% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 8.65% stake in Protagonist Therapeutics, Inc., 5,413,690 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 8.65%
- Shares
- 5,413,690
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 8.65% | 5,413,690 |
Source
Related
- Protagonist Therapeutics, Inc.
- The Vanguard Group
- Protagonist Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Ali Asif · Oct 2, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026